Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 4 Grant or award Chief Medical Officer acquired 50,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale Chf Scientific Operations Off sold 21,224 shares at $4.53 ($96,145)
  4. 4/A Insider Changes in Ownership
  5. 4/A Insider Changes in Ownership
  6. 4/A Insider Changes in Ownership
  7. 4/A Insider Changes in Ownership
  8. 4 Grant or award CEO and President acquired 65,000 shares (grant or award)
  9. 4 Grant or award Chf Scientific Operations Off acquired 24,500 shares (grant or award)
  10. 4 Grant or award VP, Controller acquired 9,500 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 23,500 shares (grant or award)
  12. 4 Shares withheld for taxes CEO and President gave up 15,469 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 3,061 shares (to pay taxes)
  14. 4 Shares withheld for taxes VP, Controller gave up 2,130 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chf Scientific Operations Off gave up 6,554 shares (to pay taxes)
  16. 4 Shares withheld for taxes CEO and President gave up 6,479 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chf Scientific Operations Off gave up 2,157 shares (to pay taxes)
  18. 4 Shares withheld for taxes VP, Controller gave up 394 shares (to pay taxes)
  19. 4 Open-market sale 10% owner sold 158,901 shares at an average $1.71 ($271,715)
  20. 4 Open-market sale 10% owner sold 61,992 shares at an average $1.84 ($114,251)

Page 3 of 20 · 382 filings